Handmer M, Martin J, Tiu A
Department of Urology, Royal Newcastle Centre, Australia.
Department of Radiation Oncology, Calvary Mater Newcastle, Australia.
Urology. 2020 Jun;140:64-69. doi: 10.1016/j.urology.2020.01.046. Epub 2020 Mar 16.
To describe patients presenting with urologic complications following pelvic radiation therapy and estimate the financial costs incurred in their treatment.
In the year ending June 2018, all urology admissions at Royal Newcastle Centre were reviewed for diagnostic codes pertaining to urethral or ureteric strictures, cystitis, and haematuria. Presentations were complications following radiotherapy if a diagnosis of radiation cystitis or stricture was recorded, and there was relevant prior radiotherapy. The Independent Hospital Pricing Authority's National Weighted Activity Unit (NWAU) 2018 calculators, admission data and the National Efficient Price were used to estimate costs of care. HNELHD HREC granted ethics approval (AU201808-10).
Complications following radiotherapy accounted for 65 admissions in 53 discrete patients, accounting for 206 bed days and 3.7% of the 1748 total urology admissions in 1 year. The majority (86%) of admissions had at least 1 operation. Mean time since radiotherapy was 7 years (range 1-30). Mean number of operations related to complications following radiotherapy was 3 (range 0-11). Readmissions were more frequent (mean 1.9 admissions/year) than other urology inpatients (mean 1.3 admissions/year, P < .001). Mean NWAU18 value was 4.12 (range 2-8.3). Admission and procedure costs were AUD $1,346,700, secondary malignancies were $9,000 and emergency department costs were $45,864 for a combined total of $1,401,591.
Patients requiring urological admission with complications following radiotherapy use more resources, stay for longer, have more operations and return more frequently than other urology patients. Conservative estimates of cost $25,900 per patient in the study year alone.
描述盆腔放射治疗后出现泌尿系统并发症的患者,并估算其治疗所需的财务成本。
在截至2018年6月的一年时间里,对皇家纽卡斯尔中心所有泌尿外科住院病例进行审查,查找与尿道或输尿管狭窄、膀胱炎及血尿相关的诊断编码。如果记录有放射性膀胱炎或狭窄的诊断,且有相关既往放疗史,则这些病例属于放疗后的并发症。使用独立医院定价机构的2018年全国加权活动单位(NWAU)计算器、住院数据和全国有效价格来估算护理成本。亨特新英格兰地区卫生区人类研究伦理委员会批准了伦理许可(AU201808 - 10)。
放疗后并发症导致53例不同患者入院65次,共计206个住院日,占该年1748例泌尿外科总住院病例的3.7%。大多数(86%)入院患者至少接受过1次手术。放疗后的平均时间为七年(范围1 - 30年)。与放疗后并发症相关的平均手术次数为3次(范围0 - 11次)。再次入院比其他泌尿外科住院患者更频繁(平均每年1.9次入院)(其他泌尿外科住院患者平均每年1.3次入院,P < 0.001)。平均NWAU18值为4.12(范围2 - 8.3)。住院及手术费用为1,346,700澳元,继发性恶性肿瘤费用为9,000澳元,急诊科费用为45,864澳元,总计1,401,591澳元。
因放疗后并发症而需泌尿外科住院治疗的患者比其他泌尿外科患者使用更多资源,住院时间更长,接受手术更多,且再次入院更频繁。仅在研究年度,保守估计每位患者的费用为25,900澳元。